GeneQuine Biotherapeutics

Hespe, Lower Saxony, Germany, 21079

http://www.genequine.com/de/

Company profile

GeneQuine Biotherapeutics company profile

GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.

Business identity

Website: http://www.genequine.com/de/
Phone number: 49 40 766 29 28 51
Operating status: Active
Company type: For Profit
Employee range: 1-10 employees
Revenue range: $0-$1M
Founded: 2011-01-01, Year

LinkedIn X

Headquarters

Headquarters: Hespe, Lower Saxony, Germany
Postal code: 21079
Country code: DE
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 4
Total equity funding: $6.6M
Last funding: Series A / $6.6M / 2021-02-15
Last equity funding: Series A / $6.6M
Investors: 5
Lead investors: 2
Articles: 1

Categories and groups

Biopharma Biotechnology Developer Tools Health Care Biotechnology Health Care Science and Engineering Software

Founders and investors

Lead investors

Investitionsbank des Landes BrandenburgPacira Pharmaceuticals

Investors

HTGF (High-Tech Gruenderfonds)IFB InnovationsstarterInvestitionsbank des Landes BrandenburgMeusinvest (Noshaq)Pacira Pharmaceuticals